Pliant Therapeutics Ratios (2019-2025) | PLRX

Ratios Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 38.11%-472.25%-343.46%-430.77%-1,051.33%-1,276.19%-1,679.81%-1,227.16%-2,249.80%-592.22%-2,065.79%-1,784.22%-2,818.92%-16,609.68%7,029.54%5,352.29%3,227.12%
EBIT Margin 38.04%-471.56%-346.09%-430.52%-1,054.23%-1,280.27%-1,684.04%-1,230.57%-2,258.69%-594.15%-2,155.67%-1,903.31%-3,160.29%-19,083.87%7,376.10%5,635.60%3,468.59%
EBITDA Margin 38.32%-474.72%-343.21%-431.08%-1,050.69%-1,276.86%-1,680.43%-1,235.22%-2,309.77%-598.42%-2,146.42%-1,758.98%-2,771.85%-16,976.61%7,049.81%5,372.06%3,222.82%
Operating Margin 38.04%-471.56%-346.09%-430.52%-1,054.23%-1,280.27%-1,684.04%-1,230.57%-2,258.69%-594.15%-2,155.67%-1,903.31%-3,160.29%-19,083.87%7,376.10%5,635.60%3,468.59%
Net Margin -472.25%-343.46%-430.77%-1,051.33%-1,276.19%-1,679.81%-1,227.16%-2,249.80%-592.22%-2,065.79%-1,784.22%-2,818.92%-16,609.68%7,029.54%5,352.29%3,227.12%
FCF Margin -45.28%207.94%-334.75%-386.51%-639.70%-1,120.29%-1,427.95%-1,023.36%-1,692.71%-494.09%-1,295.14%-1,598.22%-2,285.21%-10,226.61%6,148.44%5,032.76%2,586.63%
Efficiency
Assets Average 320.56M303.93M285.39M265.49M244.92M227.67M209.12M190.82M280.90M363.90M474.25M586.39M557.68M526.31M516.88M502.67M464.70M421.31M370.86M322.30M288.21M
Equity Average 308.08M291.70M273.62M254.07M232.21M209.75M186.43M160.79M242.39M325.17M437.63M547.49M518.06M488.31M455.45M415.00M369.25M324.95M280.62M238.62M210.19M
Invested Capital -76.30M315.82M300.35M283.06M264.17M243.98M220.44M199.06M173.79M157.66M346.89M323.27M571.88M543.05M513.07M483.63M467.33M422.75M375.96M334.29M287.45M250.44M230.75M
Asset Utilization Ratio 0.120.140.050.050.040.030.030.050.030.030.020.010.010.000.000.000.00-0.01
Leverage & Solvency
Interest Coverage Ratio -171.34-106.14-117.98-135.35-148.36-150.43-146.53-117.73-69.86-70.71-63.93-73.76-56.36-34.69
Equity Ratio -0.640.960.960.960.960.950.940.900.880.800.890.890.940.930.930.920.840.810.780.770.750.730.72
Times Interest Earned -171.34-106.14-117.98-135.35-148.36-150.43-146.53-117.73-69.86-70.71-63.93-73.76-56.36-34.69
Valuation
Enterprise Value -102.77M-312.47M-294.00M-276.89M-264.10M-243.98M-221.04M-200.60M-178.28M-163.60M-360.24M-331.19M-577.31M-555.16M-523.61M-494.25M-482.39M-436.61M-404.51M-355.72M-305.64M-262.87M-241.80M
Return Ratios
Return on Sales 0.38%-4.72%-3.43%-4.31%-10.51%-12.76%-16.80%-12.27%-22.50%-5.92%-20.66%-17.84%-28.19%-166.10%-43.80%-102.11%-688.48%70.30%53.52%32.27%
Return on Capital Employed -0.14%-0.27%-0.32%-0.40%-0.46%-0.54%-0.65%-0.45%-0.37%-0.31%-0.29%-0.33%-0.37%-0.40%-0.44%-0.52%-0.59%-0.69%-0.73%-0.69%
Return on Assets -0.07%-0.14%-0.26%-0.31%-0.37%-0.43%-0.49%-0.57%-0.40%-0.34%-0.28%-0.25%-0.28%-0.31%-0.33%-0.37%-0.43%-0.50%-0.59%-0.64%-0.61%
Return on Equity -0.07%-0.14%-0.28%-0.32%-0.40%-0.46%-0.55%-0.68%-0.47%-0.38%-0.30%-0.26%-0.30%-0.33%-0.37%-0.45%-0.55%-0.65%-0.78%-0.87%-0.83%